Elevance Health - Asset Resilience Ratio
Elevance Health (0HG8) has an Asset Resilience Ratio of 21.30% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2001–2025)
This chart shows how Elevance Health's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.
Liquid Assets Composition Over Time
This chart breaks down Elevance Health's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $25.88 Billion | 21.3% |
| Total Liquid Assets | $25.88 Billion | 21.30% |
Asset Resilience Insights
- Good Liquidity Position: Elevance Health maintains a healthy 21.30% of assets in liquid form.
- This level provides good financial flexibility while maintaining productive asset deployment.
- The company has significant short-term investments, indicating active treasury management.
Elevance Health Industry Peers by Asset Resilience Ratio
Compare Elevance Health's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
| No industry peers found with asset resilience data. | ||
Annual Asset Resilience Ratio for Elevance Health (2001–2025)
The table below shows the annual Asset Resilience Ratio data for Elevance Health.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 21.30% | $25.88 Billion | $121.49 Billion | -0.26pp |
| 2024-12-31 | 21.56% | $25.20 Billion | $116.89 Billion | -5.63pp |
| 2023-12-31 | 27.19% | $29.61 Billion | $108.93 Billion | +1.93pp |
| 2022-12-31 | 25.26% | $25.95 Billion | $102.75 Billion | -1.70pp |
| 2021-12-31 | 26.95% | $26.27 Billion | $97.46 Billion | +0.41pp |
| 2020-12-31 | 26.55% | $23.43 Billion | $88.28 Billion | +1.40pp |
| 2019-12-31 | 25.14% | $19.68 Billion | $78.25 Billion | +2.08pp |
| 2018-12-31 | 23.06% | $16.71 Billion | $72.47 Billion | -1.28pp |
| 2017-12-31 | 24.34% | $17.39 Billion | $71.46 Billion | -1.54pp |
| 2016-12-31 | 25.88% | $17.18 Billion | $66.39 Billion | -0.98pp |
| 2015-12-31 | 26.86% | $16.94 Billion | $63.06 Billion | -0.93pp |
| 2014-12-31 | 27.79% | $17.49 Billion | $62.93 Billion | -0.40pp |
| 2013-12-31 | 28.19% | $17.05 Billion | $60.49 Billion | +0.08pp |
| 2012-12-31 | 28.12% | $16.93 Billion | $60.21 Billion | -1.79pp |
| 2011-12-31 | 29.91% | $15.93 Billion | $53.26 Billion | -3.88pp |
| 2010-12-31 | 33.79% | $17.33 Billion | $51.28 Billion | +1.69pp |
| 2009-12-31 | 32.10% | $16.73 Billion | $52.13 Billion | +26.62pp |
| 2008-12-31 | 5.48% | $2.65 Billion | $48.40 Billion | -1.68pp |
| 2007-12-31 | 7.16% | $3.73 Billion | $52.06 Billion | +2.42pp |
| 2006-12-31 | 4.73% | $2.45 Billion | $51.76 Billion | -27.91pp |
| 2005-12-31 | 32.64% | $16.78 Billion | $51.41 Billion | -0.80pp |
| 2004-12-31 | 33.44% | $13.59 Billion | $40.63 Billion | -18.13pp |
| 2003-12-31 | 51.57% | $6.92 Billion | $13.41 Billion | +3.75pp |
| 2002-12-31 | 47.82% | $5.95 Billion | $12.44 Billion | -16.44pp |
| 2001-12-31 | 64.25% | $4.07 Billion | $6.34 Billion | -- |
About Elevance Health
Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. The company operates in four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to individual, employer group risk-based and fee-based, BlueCard, Medicare, Medicaid, and FEP members; health products; a broad… Read more